May 25, 2024, 11:14
Angelo Pirozzi: Comprehensive review from Lorenzo Gervaso about Rationale of neoadjuvant immunotherapy in GI malignancies
Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix), made the following post on X:
“Comprehensive review from Lorenzo Gervaso about:
- Rationale of neoadjuvant immunotherapy in GI malignancies
- completed trials in both MSI-H and MSS tumors
- Future perspectives.”
Read further.
Source: Angelo Pirozzi/X
OncoDaily
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43